Other compounds were demonstrated the suppressive effect on MDSCs viability and accumulation in tumor tissue, including apolipoprotein E (ApoE) [237], LXRβ agonists, such as GW3965 and RGX-104 [237], a novel therapeutic peptide-Fc fusion protein that targeted the S100A family proteins [238]. Here, APOE is linked to neoplasm.